Peptide Purity Testing: HPLC, Mass Spec, and What COAs Really Tell You

Written by NorthPeptide Research Team

For laboratory and research use only. Not for human consumption.

Why Peptide Purity Matters for Research

In research peptide science, the quality of your reagents determines the reliability of your results. A peptide advertised as 98% pure is making a specific analytical claim — but what does that number actually mean? How was it measured? What kinds of impurities make up the remaining 2%? And perhaps most importantly, could those impurities be affecting your experimental outcomes in ways you haven’t considered?

These aren’t abstract questions. Researchers working with bioactive peptides know that even trace contaminants — a truncated sequence, a diastereomer, residual TFA from synthesis, or an endotoxin from bacterial contamination — can confound assays, trigger non-specific immune responses, or produce false positive results in cell-based studies. The Certificate of Analysis (COA) that accompanies a research peptide is supposed to answer these questions, but understanding what each test actually measures — and what it can miss — requires a working knowledge of the analytical methods behind the numbers.

This guide breaks down the major analytical techniques used in peptide quality control: how they work, what they measure, what they can’t detect, and how to read the results on a COA with a critical eye. Whether you’re evaluating a supplier, troubleshooting unexpected experimental results, or simply trying to understand the QC data sheet that came with your latest order, this is the information you need.

HPLC: The Foundation of Peptide Purity Analysis

What It Measures

High-Performance Liquid Chromatography (HPLC) is the single most widely used analytical technique for assessing peptide purity. It is, in most cases, the method that generates the headline purity percentage on a COA. The technique separates molecules based on their differential interactions with a stationary phase (the chromatographic column) and a mobile phase (the solvent system), then detects the separated components as they elute from the column.

For peptide analysis, reversed-phase HPLC (RP-HPLC) using C18 or C8 stationary phases is the standard approach. The principle is straightforward: peptides interact with the hydrophobic alkyl chains bonded to the silica column packing material. More hydrophobic peptides are retained longer on the column, while more hydrophilic species elute earlier. By running a gradient of increasing organic solvent concentration (typically acetonitrile in water with 0.1% trifluoroacetic acid), the bound peptides are progressively released and detected, usually by UV absorbance at 214 nm or 220 nm — wavelengths at which the peptide bond absorbs strongly.

How Purity Is Calculated

The purity number on a COA is calculated from the HPLC chromatogram using peak area integration. The area under the main peptide peak is divided by the total area of all detected peaks, and the result is expressed as a percentage. A peptide reported as “greater than 98% pure by HPLC” means that the main peak constitutes at least 98% of the total integrated UV absorbance at the detection wavelength.

This sounds clean and definitive, but it’s worth understanding the method’s limitations:

• UV detection is not universal. Compounds that don’t absorb UV light at the detection wavelength — including many salts, small molecule contaminants, and residual solvents — will not be detected and won’t affect the purity calculation. A peptide could be 99% pure by HPLC but contain significant non-UV-absorbing impurities.
• Co-elution can mask impurities. If an impurity happens to elute at the same retention time as the target peptide, it will be hidden under the main peak and won’t be counted as a separate impurity. This is particularly relevant for closely related peptide impurities like diastereomers or peptides with single amino acid deletions, which may have very similar hydrophobicity profiles.
• Different columns give different results. The same peptide sample analyzed on two different HPLC columns (different C18 brands, different pore sizes, different particle sizes) can yield different purity values. Column choice, gradient conditions, flow rate, and temperature all influence resolution and peak shape. This is why a well-documented COA should specify the HPLC conditions used.
• The integration baseline matters. How the analyst sets the integration baseline — where peaks start and stop, how shoulder peaks are handled — can significantly affect the calculated purity. Manual integration introduces operator judgment; automated integration applies algorithms that may handle complex chromatograms differently than a human analyst would.

HPLC Method Variations

While RP-HPLC is the standard for purity determination, other chromatographic modes provide complementary information:

Size-exclusion chromatography (SEC) separates molecules by molecular weight and is used to detect aggregation — peptide molecules that have associated into dimers, trimers, or larger assemblies. Aggregation is particularly relevant for peptides that contain cysteine residues, which can form intermolecular disulfide bonds.

Ion-exchange chromatography (IEX) separates molecules by charge and can resolve impurities that RP-HPLC misses, particularly deamidation products (which differ from the parent peptide by a single charge) and other charge variants.

Hydrophilic interaction chromatography (HILIC) provides separation based on hydrophilicity and can complement RP-HPLC for highly polar peptides or impurities that elute near the void volume in reversed-phase systems.

A comprehensive QC program may employ multiple chromatographic modes to provide orthogonal assessment of purity — detecting different classes of impurities that any single method might miss.

Mass Spectrometry: Confirming Identity

What It Measures

While HPLC tells you how pure a sample is, mass spectrometry (MS) tells you what is in it. MS measures the mass-to-charge ratio (m/z) of ionized molecules, providing a precise molecular weight measurement that serves as the primary confirmation of peptide identity. If you ordered a peptide with a theoretical molecular weight of 1,267.5 Da and the mass spectrum shows a dominant signal at 1,267.5 Da, you have strong evidence that the main component is indeed the correct peptide.

Common MS Techniques for Peptides

MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization — Time of Flight) is the most commonly used MS technique for routine peptide identity confirmation. The peptide sample is mixed with a UV-absorbing matrix compound and spotted onto a metal plate. A pulsed laser irradiates the spot, causing the matrix to absorb the laser energy and transfer it to the peptide, which is ionized and ejected into the flight tube. The time it takes for ions to reach the detector is proportional to their mass-to-charge ratio, providing a mass spectrum.

MALDI-TOF is fast, relatively simple, tolerant of common buffer salts, and provides good mass accuracy for peptides (typically within plus or minus 0.1% of the theoretical mass). It predominantly produces singly charged ions ([M+H]+), which simplifies spectrum interpretation. Most peptide supplier COAs that include MS data are reporting MALDI-TOF results.

ESI-MS (Electrospray Ionization Mass Spectrometry) ionizes peptides from solution by spraying the sample through a charged capillary, producing a fine mist of charged droplets that evaporate to yield multiply charged peptide ions. ESI produces a characteristic charge state envelope — multiple peaks representing the same peptide with different numbers of protons attached (e.g., [M+2H]2+, [M+3H]3+, [M+4H]4+). Deconvolution algorithms convert this envelope to a single molecular weight value.

ESI-MS is particularly powerful when coupled with HPLC (LC-MS), allowing simultaneous separation and mass identification of each component in a mixture. This hyphenated technique can identify specific impurities that appear as separate peaks on the HPLC chromatogram — determining whether a minor peak represents a truncated peptide, an oxidation product, a deamidation product, or an unrelated contaminant.

MS/MS (Tandem Mass Spectrometry) takes identification a step further by fragmenting selected ions and analyzing the resulting fragment ions. For peptides, collision-induced dissociation (CID) produces predictable fragmentation patterns along the peptide backbone (b-ions and y-ions), effectively providing a partial or complete sequence confirmation. This is critical for distinguishing between peptides of identical molecular weight but different amino acid sequences — a situation that can arise with diastereomers or peptides containing isomeric amino acid pairs (e.g., leucine and isoleucine, which have identical masses).

What Mass Spec Can and Cannot Tell You

Mass spectrometry is excellent at confirming that the correct peptide is present and identifying the molecular nature of impurities. However, MS is not inherently quantitative in the way that HPLC is. The signal intensity in a mass spectrum depends on multiple factors including ionization efficiency, matrix effects, and instrument tuning — not just concentration. Therefore, MS is not typically used to determine purity percentages. Rather, it serves as the identity confirmation that complements HPLC’s quantitative purity assessment.

One important caveat: if a COA shows a clean MS spectrum with a single dominant peak at the correct molecular weight, this confirms identity but does not guarantee purity. A peptide sample could contain 10% of a closely related impurity that simply ionizes less efficiently and appears as a minor MS peak despite being present at a significant concentration.

Endotoxin Testing: The Safety Gatekeeper

Why Endotoxins Matter

Endotoxins — specifically, lipopolysaccharides (LPS) from the outer membrane of Gram-negative bacteria — are arguably the most important contaminant class for any peptide that will be used in biological research. Endotoxins are extraordinarily potent activators of the innate immune system, capable of triggering inflammatory cascades at concentrations as low as picograms per milliliter. In cell culture experiments, even trace endotoxin contamination can activate NF-kB signaling, induce cytokine production, and alter gene expression profiles in ways that mimic or mask the biological effects of the peptide being studied.

This is not a theoretical concern. Researchers have documented cases where “biological activity” attributed to a peptide or protein preparation was subsequently shown to be caused by endotoxin contamination. If you’re running an in vitro study and your peptide appears to have pro-inflammatory or immunostimulatory effects, the first question to ask is whether the result could be an endotoxin artifact.

The LAL Assay

The standard method for endotoxin detection is the Limulus Amebocyte Lysate (LAL) assay, developed from the observation that the blood of horseshoe crabs (Limulus polyphemus) clots in the presence of bacterial endotoxins. The assay uses a lysate prepared from the amebocytes (blood cells) of horseshoe crabs, which contains Factor C — a serine protease zymogen that is specifically activated by endotoxins, triggering a coagulation cascade.

Three variants of the LAL assay are in common use:

• Gel-clot assay — The simplest format. The sample is mixed with LAL reagent and incubated. If endotoxins are present above the sensitivity threshold, the mixture forms a solid gel. This is a qualitative (pass/fail) or semi-quantitative test, with sensitivity typically around 0.03 EU/mL (Endotoxin Units per milliliter).
• Turbidimetric assay — Measures the increase in turbidity (optical density) as the LAL reagent reacts with endotoxins. The rate of turbidity development is proportional to the endotoxin concentration, providing a quantitative result. Kinetic turbidimetric assays can detect endotoxin levels as low as 0.01 EU/mL.
• Chromogenic assay — Uses a synthetic chromogenic substrate that is cleaved by the activated LAL enzyme, releasing a colored product (typically para-nitroaniline, which absorbs at 405 nm). The intensity of color development is proportional to endotoxin concentration. This is the most commonly used quantitative LAL method, with sensitivity down to 0.005 EU/mL.

Recombinant Factor C (rFC) Assays

An alternative to LAL-based testing uses recombinant Factor C produced in engineered cell lines rather than extracted from horseshoe crab blood. The rFC assay uses the same biological principle — Factor C activation by endotoxins — but eliminates the need for horseshoe crab harvesting and avoids potential batch-to-batch variability in LAL reagent preparation. The rFC approach is highly specific for endotoxin and does not cross-react with beta-glucans from fungal cell walls, which can cause false-positive results in some LAL assay formats.

Interpreting Endotoxin Results on a COA

Endotoxin levels on a COA are reported in Endotoxin Units per milligram (EU/mg) of peptide or per milliliter (EU/mL) of reconstituted solution. For research peptides intended for in vitro studies, a commonly cited acceptable threshold is less than 1 EU/mg. For peptides used in animal studies, stricter limits (less than 0.1 EU/mg) may be appropriate depending on the route of administration and the study design.

Be aware that not all peptide suppliers include endotoxin testing on their COAs. If endotoxin data is absent, this does not necessarily mean the peptide is contaminated — it may simply mean the test wasn’t performed. For any study where immune endpoints are being measured, confirming endotoxin levels is essential, and independent testing can be performed if supplier data is unavailable.

Amino Acid Analysis: Quantifying What You Have

What It Measures

Amino acid analysis (AAA) is the gold standard for determining the absolute quantity of peptide in a sample — the net peptide content. This is a distinct measurement from HPLC purity. A peptide might be 98% pure by HPLC (meaning 98% of the detected peaks correspond to the target peptide), but the sample might contain only 70% peptide by weight, with the remaining 30% consisting of counterions (TFA, acetate), moisture, and other non-peptide components that don’t appear on the HPLC chromatogram.

AAA works by completely hydrolyzing the peptide — breaking every peptide bond — and then quantifying each individual amino acid. The sample is heated in 6M hydrochloric acid at 110 degrees Celsius for 18 to 24 hours, a process that cleaves all peptide bonds and releases the constituent amino acids as a free amino acid mixture. These free amino acids are then separated and quantified, typically by ion-exchange chromatography with ninhydrin detection or by RP-HPLC after pre-column derivatization with reagents like phenylisothiocyanate (PITC) or o-phthalaldehyde (OPA).

What AAA Tells You That HPLC Cannot

AAA provides several pieces of information that no other single technique can deliver:

• Net peptide content — The actual mass of peptide per milligram of powder. This is essential for accurate concentration calculations when preparing stock solutions. If you weigh out 10 mg of peptide powder and assume it’s 100% peptide, but the net peptide content is actually 75%, your working concentration will be 25% lower than intended.
• Amino acid composition — The molar ratios of each amino acid should match the theoretical ratios predicted by the peptide’s known sequence. Significant deviations can indicate contamination with other peptides, incomplete synthesis, or sample degradation.
• Confirmation of identity — While AAA cannot determine the sequence order, it can confirm that the correct amino acids are present in the correct ratios, providing an independent identity check that complements MS data.

Limitations

AAA has well-documented limitations that researchers should understand. Acid hydrolysis conditions destroy certain amino acids: tryptophan is completely degraded, cysteine is partially destroyed (unless the sample is oxidized to cysteic acid prior to hydrolysis), and serine and threonine are partially degraded (correction factors are applied). Asparagine and glutamine are converted to aspartic acid and glutamic acid respectively during hydrolysis, so they cannot be independently quantified. These limitations mean that AAA results should be interpreted with knowledge of the peptide’s expected composition and the specific hydrolysis conditions used.

Additional QC Tests You May Encounter

Peptide Sequencing

For critical applications where absolute sequence confirmation is required, Edman degradation provides definitive N-terminal sequencing. The method sequentially removes and identifies one amino acid at a time from the N-terminus of the peptide, confirming the sequence order that mass spectrometry and amino acid analysis cannot individually establish. However, Edman degradation is slow, expensive, and typically limited to the first 20-30 residues, making it impractical for routine QC but valuable for reference standard characterization.

Water Content (Karl Fischer Titration)

Lyophilized peptide powders are hygroscopic and absorb moisture from the atmosphere. Karl Fischer titration measures the water content of the sample, which is important for accurate mass-based calculations. A peptide powder containing 8% water by weight will have correspondingly less actual peptide per milligram weighed. While water content doesn’t affect HPLC purity measurements, it directly impacts the accuracy of gravimetric concentration calculations.

Counterion Content

Most synthetic peptides are supplied as trifluoroacetate (TFA) salts, a consequence of the TFA used in HPLC purification. TFA counterions can constitute 10-20% of the total powder weight for small peptides with multiple basic residues. Some suppliers offer acetate or hydrochloride salt forms as alternatives, which may be preferable for specific applications (TFA can interfere with certain cell-based assays at higher concentrations). Counterion content is rarely reported on standard COAs but can be determined by ion chromatography or by calculating the expected counterion contribution from the peptide’s charge state.

Appearance and Solubility

While seemingly basic, visual inspection and solubility testing provide useful quality indicators. Research-grade lyophilized peptides should appear as a white to off-white powder (coloration may indicate degradation products or manufacturing residues). Solubility testing confirms that the peptide dissolves in the expected solvent system at the expected concentration, which can reveal aggregation problems or salt form issues that wouldn’t necessarily appear on chromatographic analysis.

Reading a COA: A Practical Checklist

When you receive a COA with a peptide order, here’s what to look for and what questions to ask:

Test	What to Check	Red Flags
HPLC Purity	Method details (column, gradient, detection wavelength), chromatogram included?	Purity stated without method details; no chromatogram provided; unusually high purity claims without supporting data
Mass Spec	Observed MW matches theoretical MW (within instrument accuracy); spectrum included?	MW discrepancy greater than 1 Da; no spectrum shown; multiple major peaks in spectrum
Endotoxin	Level reported in EU/mg; method stated (LAL gel-clot, chromogenic, or rFC)	Test not performed; level reported as “pass” without quantitative value; very high levels
AAA / Net Peptide Content	Net peptide content percentage; amino acid ratios match expected composition	Net peptide content below 50%; amino acid ratios significantly deviate from theoretical
Appearance	White to off-white lyophilized powder	Unusual coloration; oily or wet appearance; visible particulates
Lot Number	Present and matches vial label	No lot number; mismatch between COA and product label

One critical point: a COA is only as reliable as the laboratory that produced it. Third-party analytical testing by an independent laboratory provides a higher level of assurance than in-house testing by the supplier, though both have their place in a quality assurance framework. For critical research applications, independent verification of key parameters — particularly purity and endotoxin levels — is strongly recommended.

For more on interpreting COA documents, see our guide to reading peptide COAs.

Regulatory and Standards Framework

The analytical methods described above don’t exist in a vacuum — they operate within a regulatory and standards framework that defines how testing should be performed and what constitutes acceptable quality:

ICH Guidelines — The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use publishes guidelines that serve as the global standard for pharmaceutical quality testing. ICH Q6B specifically addresses specifications for biotechnological and biological products, including peptides, and outlines the types of tests required for characterization and release testing. While ICH guidelines technically apply to pharmaceutical products rather than research reagents, they represent best practices that inform quality-conscious research peptide suppliers.

USP Standards — The United States Pharmacopeia publishes monographs and general chapters that define analytical methods and acceptance criteria for pharmaceutical peptides. USP Chapter 621 covers chromatographic methods, Chapter 85 covers endotoxin testing, and Chapter 1058 covers analytical instrument qualification. These standards provide validated, consensus-based methodologies that ensure reproducibility across laboratories.

European Pharmacopoeia (Ph. Eur.) — Provides parallel standards to the USP for European markets, with general monographs on peptide characterization and analytical testing that are harmonized with ICH guidelines.

For research-grade peptides, strict compliance with pharmaceutical GMP standards is not typically required or expected. However, suppliers who align their QC programs with the principles outlined in these standards — using validated analytical methods, maintaining documented procedures, and providing comprehensive COA data — demonstrate a commitment to quality that researchers should look for when evaluating suppliers.

The Bottom Line for Researchers

Peptide purity is not a single number — it’s a multidimensional assessment that requires multiple orthogonal analytical techniques, each measuring different aspects of quality. HPLC tells you about chromatographic purity. Mass spectrometry confirms identity. Endotoxin testing ensures biological safety. Amino acid analysis quantifies actual peptide content. No single technique provides a complete picture, and a truly informative COA should include results from at least HPLC and MS, with endotoxin data for any peptide intended for biological assays.

Understanding these methods doesn’t just help you evaluate suppliers — it helps you design better experiments. Knowing the limitations of HPLC purity measurements, for example, might prompt you to include appropriate controls in your study. Understanding that a peptide is 98% pure by HPLC but only 75% peptide by weight will prevent concentration errors in your stock solutions. And knowing whether your peptide has been tested for endotoxins could save you months of troubleshooting an inflammatory response that had nothing to do with the peptide itself.

In research, the quality of your conclusions can never exceed the quality of your reagents. Taking the time to understand peptide purity testing is an investment in the reliability of every experiment that follows.

Summary of Key Research References

Study	Year	Type	Focus	Reference
Aguilar et al.	2004	Methods Review	HPLC analysis and purification of peptides	PMC7119934
Batas & Kominami et al.	2023	Regulatory Review	Reference standards to support quality of synthetic peptide therapeutics	PMC10338602
Leurs et al.	2015	Analytical Methods	LC-HRMS for peptide drug quality control	PMC4406950
Mant & Hodges et al.	2016	Best Practices	Recommendations for peptide generation, quantification, and handling for MS-based assays	PMC4830481
Pikal-Cleland et al.	2025	Regulatory Review	Regulatory guidelines for analysis of therapeutic peptides and proteins	PMC11806371
Chen et al.	2023	Analytical Methods	Amino acid analysis for peptide quantitation using LC-MRM-MS	PMC10444640
Bolden et al.	2021	Review	LAL technology for endotoxin detection: methods, progress, and perspectives	PMC8150811
Iwaki et al.	2013	Mechanistic Review	Biochemical principle of Limulus test for detecting bacterial endotoxins	PMC3756735

---

Research Disclaimer

For laboratory and research use only. Not for human consumption.

This article is intended solely as a summary of published scientific research. It does not constitute medical advice, treatment recommendations, or an endorsement for any therapeutic purpose. The research discussed herein is predominantly preclinical, and results may not translate to human outcomes. Researchers should consult relevant institutional review boards and regulatory guidelines before designing studies involving these compounds.

NorthPeptide supplies research-grade peptides for legitimate scientific investigation. All products are sold strictly for laboratory and research purposes.